Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09TSM
|
|||
Drug Name |
Imidazoleisoindoles derivative 2
|
|||
Synonyms |
PMID29473428-Compound-37
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
HANGZHOU INNOGATE PHARMA CO., LTD
|
|||
Structure |
Download2D MOL |
|||
Formula |
C22H25FN2O2
|
|||
Canonical SMILES |
C1C2CC3CC(C2)(CC1C3O)C(CC4C5=C(C=CC=C5F)C6=CN=CN46)O
|
|||
InChI |
1S/C22H25FN2O2/c23-16-3-1-2-15-18-10-24-11-25(18)17(20(15)16)6-19(26)22-7-12-4-13(8-22)21(27)14(5-12)9-22/h1-3,10-14,17,19,21,26-27H,4-9H2
|
|||
InChIKey |
SPKRAWSVCLOAAN-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Indoleamine 2,3-dioxygenase 1 (IDO1) | Target Info | Inhibitor | [1] |
Target's Patent Info | Indoleamine 2,3-dioxygenase 1 (IDO1) | Target's Patent Info | [1] | |
BioCyc | Superpathway of tryptophan utilization | |||
Tryptophan degradation | ||||
L-kynurenine degradation | ||||
Tryptophan degradation to 2-amino-3-carboxymuconate semialdehyde | ||||
NAD de novo biosynthesis | ||||
KEGG Pathway | Tryptophan metabolism | |||
Metabolic pathways | ||||
African trypanosomiasis | ||||
NetPath Pathway | TSLP Signaling Pathway | |||
IL5 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | ||||
Pathwhiz Pathway | Tryptophan Metabolism | |||
Reactome | Tryptophan catabolism | |||
WikiPathways | Tryptophan metabolism | |||
Metabolism of amino acids and derivatives |
References | Top | |||
---|---|---|---|---|
REF 1 | A patent review of IDO1 inhibitors for cancer.Expert Opin Ther Pat. 2018 Apr;28(4):317-330. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.